Topera Medical’s FDA-Cleared RhythmView™ System Featured in Eight Presentations at the 2012 Scientific Sessions of the American Heart Association

SAN DIEGO--(BUSINESS WIRE)--Topera today announced that its RhythmView™ 3D Electrophysiological Mapping System will be featured in eight presentations at the 2012 American Heart Association Scientific Sessions, November 3-7 in Los Angeles, CA. The presentations will provide clinicians with key information about RhythmView’s ability to routinely identify the sources that sustain atrial fibrillation - specifically focal impulses and rotors.

Schedule of scientific presentations (All times are local; all events take place in the Los Angeles Convention Center unless otherwise indicated.)

Monday, November 5

9:00	Abstract Poster Session APS.406.01.
	Novel Technologies and Techniques for Ablation of Atrial Fibrillation
	18879/4047 – Procedural Success in the CONFIRM Trial is Independent of Use of Irrigated or Non-irrigated Ablation Catheters
9:00	Abstract Poster Session APS.406.01.
	Novel Technologies and Techniques for Ablation of Atrial Fibrillation
	12207/4046 - Focal Impulse and Rotor Modulation-Guided Ablation More Efficiently Prolongs Atrial Fibrillation Cycle Length than Convention Ablation
2:00	Abstract Oral Session AOS.406.01. Impact of New Technology in Ablation of Atrial Fibrillation
	11126 - Elimination of Sources for Human Atrial Fibrillation (Focal Impulse and Rotor
	Modulation, FIRM) Organizes and Acutely Terminates AF Prior to Pulmonary Vein
	Isolation: A Multicenter Experience
3:15	Case Theatre Lecture - CT.06.
	Learning at the Movies: Atrial Fibrillation Ablation in Late 2012 - State of the Art

Tuesday, November 6

9:00	Abstract Oral Session AOS.404.06. Changing Paradigms in Managing Atrial Arrhythmias
	18071 - Heart Failure, Obesity and Sleep Apnea May Mediate Atrial Fibrillation by
	Enabling Sustaining Rotors
2:00	Special SS.14. Atrial Fibrillation: 2012 and the Future
	Electrical Rotors in Human Atrial Fibrillation

Wednesday, November 7

9:00	Abstract Oral Session AOS.404.05. New Insights into Mechanisms of Clinical Arrhythmia
	13734 - Human Atrial Fibrillation is Initiated by Repolarization Alternans and the Formation of a Predominant Spiral Wave
9:00	Abstract Oral Session AOS.404.04. Mechanisms of Atrial Fibrillation: Clinical Implications
	9976 - Human Atrial Fibrillation Initiates by Formation of a Dominant Spiral Wave at the Site Where Triggers Cause Dynamic Conduction Slowing

About Topera Medical

www.toperamedical.com

Topera Medical (Topera, Inc.) has developed the RhythmView™, 3D Electrophysiologic Mapping System to assist electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias. The RhythmView system, including the RhythmView console and FIRMap™ catheter, is designed to improve patient outcomes by enabling electrophysiologists to view a dynamic representation of the electrical activity of the heart, supporting the diagnosis of and treatment planning for a variety of arrhythmias including atrial flutter, atrial tachycardia, ventricular tachycardia, and atrial fibrillation (AF).